Geopolitical disruptions in global shipping routes increasingly threaten India's pharmaceutical supply chains. Discuss with examples.

India is a leading supplier of generic medicines, yet its factories run on imported raw materials that travel through a few maritime chokepoints. Conflict on these routes now converts into medicine shortages at home, making shipping security a public-health concern.

How shipping disruptions transmit into drug shortages

• Chokepoint concentration: India's westbound trade moves through the Red Sea–Suez and West Asian corridors; hostilities force longer Cape of Good Hope detours, raising freight, insurance and transit time. The Economic Survey 2024-25 listed the Red Sea crisis, alongside the Ukraine war and Panama Canal drought, as a source of global trade uncertainty [3].
• Input dependence: for some bulk drugs, import dependence is 80–100% [2], so a delayed consignment halts entire production lines.
• Price-rigidity trap: essential medicines carry fixed ceiling prices under the DPCO, 2013, administered by the NPPA [1]; when landed input costs spike, manufacturing turns unviable and firms exit.

Example: the cisplatin–carboplatin shortage (2026)

• Global platinum prices more than doubled while shipping through West Asia was disrupted, squeezing makers of these platinum-based chemotherapy drugs and triggering a nationwide shortage [5].
• The NPPA invoked extraordinary powers under Para 19 of DPCO [1] to raise ceiling prices by 50% (cisplatin ₹7.26 → ₹10.89 per ml) as a one-time, six-month-review measure [5].
• Impact was uneven — government hospitals largely stabilised supply while private-hospital patients faced delayed chemotherapy cycles, an equity concern in cancer care [5].

Deeper structural exposure

• Platinum Group Metals are import-dependent critical minerals sourced largely from South Africa; the National Critical Mineral Mission (2025) seeks to cut such dependence [4].
• Response measures include the PLI scheme for bulk drugs/APIs, which has commissioned domestic capacity for several key starting materials [2].

Shipping geopolitics has thus become a determinant of drug availability, linking maritime security to the right to health. Diversified sourcing, strategic buffer stocks of critical APIs, cost-indexed price revision, and deeper API self-reliance can make affordability and availability mutually reinforcing rather than competing goals.